Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Nov;88(5):1636–1642. doi: 10.1172/JCI115477

Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.

K B Margulies 1, M A Perrella 1, L J McKinley 1, J C Burnett Jr 1
PMCID: PMC295690  PMID: 1658047

Abstract

The renal natriuretic actions of endogenous atrial natriuretic factor are enhanced by neutral endopeptidase inhibition (NEP-I). Recognizing that activation of the renin-angiotensin-aldosterone system in congestive heart failure (CHF) antagonizes the renal actions of atrial natriuretic factor, we hypothesized that angiotensin II antagonism with converting enzyme inhibition would potentiate the renal actions of NEP-I in CHF. To test this hypothesis, the renal responses to a specific NEP-I (SQ 28,603) were assessed in dogs with eight days of experimental CHF produced by rapid ventricular pacing. The renal natriuretic responses to NEP-I in experimental CHF were significant. In the same model of CHF, chronic angiotensin antagonism with converting enzyme inhibition potentiated both renal hemodynamic and excretory responses to NEP-I. The potentiated renal hemodynamic response included significant increases in glomerular filtration rate and filtration fraction. In the CHF group with angiotensin antagonism, an intrarenal infusion of low-dose angiotensin abolished the potentiated renal responses to NEP-I, supporting the concept that intrarenal angiotensin antagonism, rather than improved systemic hemodynamics or potentiation of other peptide systems, mediated the enhanced renal responses to NEP-I in the presence of converting enzyme inhibition.

Full text

PDF
1636

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abassi Z., Haramati A., Hoffman A., Burnett J. C., Jr, Winaver J. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol. 1990 Jul;259(1 Pt 2):R84–R89. doi: 10.1152/ajpregu.1990.259.1.R84. [DOI] [PubMed] [Google Scholar]
  2. Appel R. G., Wang J., Simonson M. S., Dunn M. J. A mechanism by which atrial natriuretic factor mediates its glomerular actions. Am J Physiol. 1986 Dec;251(6 Pt 2):F1036–F1042. doi: 10.1152/ajprenal.1986.251.6.F1036. [DOI] [PubMed] [Google Scholar]
  3. Ballermann B. J., Hoover R. L., Karnovsky M. J., Brenner B. M. Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. J Clin Invest. 1985 Dec;76(6):2049–2056. doi: 10.1172/JCI112207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berg J. A., Hayashi M., Fujii Y., Katz A. I. Renal metabolism of atrial natriuretic peptide in the rat. Am J Physiol. 1988 Sep;255(3 Pt 2):F466–F473. doi: 10.1152/ajprenal.1988.255.3.F466. [DOI] [PubMed] [Google Scholar]
  5. Burnett J. C., Jr, Kao P. C., Hu D. C., Heser D. W., Heublein D., Granger J. P., Opgenorth T. J., Reeder G. S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. doi: 10.1126/science.2935937. [DOI] [PubMed] [Google Scholar]
  6. Cavero P. G., Margulies K. B., Winaver J., Seymour A. A., Delaney N. G., Burnett J. C., Jr Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation. 1990 Jul;82(1):196–201. doi: 10.1161/01.cir.82.1.196. [DOI] [PubMed] [Google Scholar]
  7. Cavero P. G., Miller W. L., Heublein D. M., Margulies K. B., Burnett J. C., Jr Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol. 1990 Aug;259(2 Pt 2):F312–F317. doi: 10.1152/ajprenal.1990.259.2.F312. [DOI] [PubMed] [Google Scholar]
  8. Chou S. Y., Faubert P. F., Porush J. G. Contribution of angiotensin to the control of medullary hemodynamics. Fed Proc. 1986 Apr;45(5):1438–1443. [PubMed] [Google Scholar]
  9. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Crozier I. G., Nicholls M. G., Ikram H., Espiner E. A., Gomez H. J., Warner N. J. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet. 1986 Nov 29;2(8518):1242–1245. doi: 10.1016/s0140-6736(86)92675-9. [DOI] [PubMed] [Google Scholar]
  11. Dunn B. R., Ichikawa I., Pfeffer J. M., Troy J. L., Brenner B. M. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res. 1986 Sep;59(3):237–246. doi: 10.1161/01.res.59.3.237. [DOI] [PubMed] [Google Scholar]
  12. Erdös E. G., Skidgel R. A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 1989 Feb;3(2):145–151. [PubMed] [Google Scholar]
  13. FUHR J., KACZMARCZYK J., KRUTTGEN C. D. Eine einfache colorimetrische Methode zur Inulinbestimmung für Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr. 1955 Aug 1;33(29-30):729–730. doi: 10.1007/BF01473295. [DOI] [PubMed] [Google Scholar]
  14. Freeman R. H., Davis J. O., Williams G. M., DeForrest J. M., Seymour A. A., Rowe B. P. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs. Circ Res. 1979 Oct;45(4):540–545. doi: 10.1161/01.res.45.4.540. [DOI] [PubMed] [Google Scholar]
  15. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  16. Hall J. E. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol. 1986 Jun;250(6 Pt 2):R960–R972. doi: 10.1152/ajpregu.1986.250.6.R960. [DOI] [PubMed] [Google Scholar]
  17. Heidemann H. T., Jackson E. K., Gerkens J. F., Branch R. A. Intrarenal hypertonic saline infusions in dogs with thoracic caval constriction. Kidney Int. 1987 Oct;32(4):488–492. doi: 10.1038/ki.1987.236. [DOI] [PubMed] [Google Scholar]
  18. Koepke J. P., DiBona G. F. Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders. Am J Physiol. 1987 May;252(5 Pt 2):F865–F871. doi: 10.1152/ajprenal.1987.252.5.F865. [DOI] [PubMed] [Google Scholar]
  19. Koseki C., Hayashi Y., Torikai S., Furuya M., Ohnuma N., Imai M. Localization of binding sites for alpha-rat atrial natriuretic polypeptide in rat kidney. Am J Physiol. 1986 Feb;250(2 Pt 2):F210–F216. doi: 10.1152/ajprenal.1986.250.2.F210. [DOI] [PubMed] [Google Scholar]
  20. Levens N. R., Peach M. J., Carey R. M. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res. 1981 Feb;48(2):157–167. doi: 10.1161/01.res.48.2.157. [DOI] [PubMed] [Google Scholar]
  21. Maher E., Cernacek P., Levy M. Heterogeneous renal responses to atrial natriuretic factor. I. Chronic caval dogs. Am J Physiol. 1989 Nov;257(5 Pt 2):R1057–R1067. doi: 10.1152/ajpregu.1989.257.5.R1057. [DOI] [PubMed] [Google Scholar]
  22. Margulies K. B., Cavero P. G., Seymour A. A., Delaney N. G., Burnett J. C., Jr Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int. 1990 Jul;38(1):67–72. doi: 10.1038/ki.1990.168. [DOI] [PubMed] [Google Scholar]
  23. Margulies K. B., Heublein D. M., Perrella M. A., Burnett J. C., Jr ANF-mediated renal cGMP generation in congestive heart failure. Am J Physiol. 1991 Apr;260(4 Pt 2):F562–F568. doi: 10.1152/ajprenal.1991.260.4.F562. [DOI] [PubMed] [Google Scholar]
  24. Mitchell K. D., Navar L. G. Enhanced tubuloglomerular feedback during peritubular infusions of angiotensins I and II. Am J Physiol. 1988 Sep;255(3 Pt 2):F383–F390. doi: 10.1152/ajprenal.1988.255.3.F383. [DOI] [PubMed] [Google Scholar]
  25. Mujais S. K., Kauffman S., Katz A. I. Angiotensin II binding sites in individual segments of the rat nephron. J Clin Invest. 1986 Jan;77(1):315–318. doi: 10.1172/JCI112293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Perrella M. A., Margulies K. B., Wei C. M., Aarhus L. L., Heublein D. M., Burnett J. C., Jr Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs. J Clin Invest. 1991 May;87(5):1649–1655. doi: 10.1172/JCI115180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Raya T. E., Lee R. W., Westhoff T., Goldman S. Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure. Circulation. 1989 Dec;80(6):1886–1892. doi: 10.1161/01.cir.80.6.1886. [DOI] [PubMed] [Google Scholar]
  28. Redfield M. M., Edwards B. S., Heublein D. M., Burnett J. C., Jr Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure. Am J Physiol. 1989 Oct;257(4 Pt 2):R917–R923. doi: 10.1152/ajpregu.1989.257.4.R917. [DOI] [PubMed] [Google Scholar]
  29. Riegger G. A., Elsner D., Kromer E. P., Daffner C., Forssmann W. G., Muders F., Pascher E. W., Kochsiek K. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation. 1988 Feb;77(2):398–406. doi: 10.1161/01.cir.77.2.398. [DOI] [PubMed] [Google Scholar]
  30. Saito Y., Nakao K., Nishimura K., Sugawara A., Okumura K., Obata K., Sonoda R., Ban T., Yasue H., Imura H. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 1987 Jul;76(1):115–124. doi: 10.1161/01.cir.76.1.115. [DOI] [PubMed] [Google Scholar]
  31. Salazar F. J., Granger J. P., Fiksen-Olsen M. J., Bentley M. D., Romero J. C. Possible modulatory role of angiotensin II on atrial peptide-induced natriuresis. Am J Physiol. 1987 Nov;253(5 Pt 2):F880–F883. doi: 10.1152/ajprenal.1987.253.5.F880. [DOI] [PubMed] [Google Scholar]
  32. Shimamori Y., Watanabe Y., Fujimoto Y. Specificity of a membrane-bound neutral endopeptidase from rat kidney. Chem Pharm Bull (Tokyo) 1986 Jan;34(1):275–280. doi: 10.1248/cpb.34.275. [DOI] [PubMed] [Google Scholar]
  33. Showalter C. J., Zimmerman R. S., Schwab T. R., Edwards B. S., Opgenorth T. J., Burnett J. C., Jr Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol. 1988 Mar;254(3 Pt 2):R453–R456. doi: 10.1152/ajpregu.1988.254.3.R453. [DOI] [PubMed] [Google Scholar]
  34. Slick G. L., DiBona G. F., Kaloyanides G. J. Renal sympathetic nerve activity in sodium retention of acute caval constriction. Am J Physiol. 1974 Apr;226(4):925–932. doi: 10.1152/ajplegacy.1974.226.4.925. [DOI] [PubMed] [Google Scholar]
  35. Smith J. B., Lincoln T. M. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol. 1987 Jul;253(1 Pt 1):C147–C150. doi: 10.1152/ajpcell.1987.253.1.C147. [DOI] [PubMed] [Google Scholar]
  36. Smits G. J., McGraw D. E., Trapani A. J. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects. Am J Physiol. 1990 May;258(5 Pt 2):F1417–F1424. doi: 10.1152/ajprenal.1990.258.5.F1417. [DOI] [PubMed] [Google Scholar]
  37. Sonnenberg H., Honrath U., Wilson D. R. In vivo microperfusion of inner medullary collecting duct in rats: effect of amiloride and ANF. Am J Physiol. 1990 Aug;259(2 Pt 2):F222–F226. doi: 10.1152/ajprenal.1990.259.2.F222. [DOI] [PubMed] [Google Scholar]
  38. Steiner A. L., Pagliara A. S., Chase L. R., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids. J Biol Chem. 1972 Feb 25;247(4):1114–1120. [PubMed] [Google Scholar]
  39. Wilkins M. R., Settle S. L., Stockmann P. T., Needleman P. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6465–6469. doi: 10.1073/pnas.87.16.6465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Winaver J., Hoffman A., Burnett J. C., Jr, Haramati A. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol. 1988 May;254(5 Pt 2):R776–R784. doi: 10.1152/ajpregu.1988.254.5.R776. [DOI] [PubMed] [Google Scholar]
  41. Zimmerman R. S., Schirger J. A., Edwards B. S., Schwab T. R., Heublein D. M., Burnett J. C., Jr Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog. Circ Res. 1987 Jul;61(1):63–69. doi: 10.1161/01.res.61.1.63. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES